| Price | 80.50p on 27-11-2025 at 16:31:50 |
|---|---|
| Change | 2.00p 2.55% |
| Buy | 81.00p |
| Sell | 80.00p |
| Last Trade: | Sell 10,000.00 at 80.10p |
| Day's Volume: | 2,348,802 |
| Last Close: | 80.50p |
| Open: | 78.50p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 80.50p - 81.00p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £349.10m |
| VWAP: | 79.94783p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 10,000 | 80.10p | Ordinary |
16:29:38 - 27-Nov-25 |
| Buy* | 25,000 | 81.00p | Ordinary |
16:26:50 - 27-Nov-25 |
| Sell* | 9,800 | 80.354p | Ordinary |
16:26:08 - 27-Nov-25 |
| Sell* | 10,000 | 80.354p | Ordinary |
16:26:01 - 27-Nov-25 |
| Sell* | 12,000 | 80.496p | Ordinary |
16:25:44 - 27-Nov-25 |
| Sell* | 12,455 | 80.354p | Ordinary |
16:16:15 - 27-Nov-25 |
| Unknown* | 1,000 | 80.50p | Ordinary |
16:15:10 - 27-Nov-25 |
| Sell* | 150,000 | 80.377p | Ordinary |
16:04:38 - 27-Nov-25 |
| Unknown* | -150,000 | 81.377p | Ordinary Correction |
16:04:38 - 27-Nov-25 |
| Buy* | 150,000 | 81.377p | Ordinary |
16:04:38 - 27-Nov-25 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
| 30th Sep 2025 7:00 am | RNS | Interim Half Year Results 2025 |
| 15th Sep 2025 7:00 am | RNS | Notice of Interim Results |
| 9th Sep 2025 7:00 am | RNS-R | Shortlisted for AIM Awards Technology of the Year |
